Terms: = Thyroid cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Treatment
11 results:
1. Comparison of neoadjuvant immunotherapy versus routine neoadjuvant therapy for patients with locally advanced esophageal cancer: A systematic review and meta-analysis.
Qin H; Liu F; Zhang Y; Liang Y; Mi Y; Yu F; Xu H; Li K; Lin C; Li L; Tian Z; Wang L
Front Immunol; 2023; 14():1108213. PubMed ID: 37033991
[TBL] [Abstract] [Full Text] [Related]
2. Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study.
Ishikawa T; Sakamaki K; Narui K; Nishimura H; Sangai T; Tamaki K; Hasegawa Y; Watanabe KI; Suganuma N; Michishita S; Sugae S; Aihara T; Tsugawa K; Kaise H; Taira N; Mukai H;
Breast; 2021 Apr; 56():70-77. PubMed ID: 33631458
[TBL] [Abstract] [Full Text] [Related]
3. Atypical metastasis of nasopharyngeal cancer: noncontiguous spread to the ipsilateral ear.
Sandler ML; Sims JR; Xing MH; Khorsand AS; Brandwein-Weber M; Lee NY; Urken ML
Clin Imaging; 2021 Apr; 72():70-74. PubMed ID: 33217673
[TBL] [Abstract] [Full Text] [Related]
4. THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Paparo SR; Camastra S; Mazzi V; Miccoli M; Benvenga S; Antonelli A
Eur J Endocrinol; 2021 Jan; 184(1):R29-R40. PubMed ID: 33112294
[TBL] [Abstract] [Full Text] [Related]
5. Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Patrizio A; Paparo SR; Marone G; Galdiero MR; Guglielmi G; Foddis R; Cristaudo A; Antonelli A
Semin Cancer Biol; 2022 Feb; 79():203-216. PubMed ID: 32569821
[TBL] [Abstract] [Full Text] [Related]
6. Down-regulation of miR-181b promotes apoptosis by targeting cyld in thyroid papillary cancer.
Li D; Jian W; Wei C; Song H; Gu Y; Luo Y; Fang L
Int J Clin Exp Pathol; 2014; 7(11):7672-80. PubMed ID: 25550803
[TBL] [Abstract] [Full Text] [Related]
7. Simultaneous non-Hodgkin lymphoma of the external auditory canal and thyroid gland: A case report.
Khaw B; Sivalingam S; Pathamanathan SS; Tan TS; Naicker M
Ear Nose Throat J; 2014 Dec; 93(12):508-11. PubMed ID: 25531844
[TBL] [Abstract] [Full Text] [Related]
8. Management of well-differentiated thyroglossal remnant thyroid carcinoma: time to close the debate? Report of five new cases and proposal of a definitive algorithm for treatment.
Plaza CP; López ME; Carrasco CE; Meseguer LM; Perucho Ade L
Ann Surg Oncol; 2006 May; 13(5):745-52. PubMed ID: 16538412
[TBL] [Abstract] [Full Text] [Related]
9. Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients.
Dubuisson AS; Beckers A; Stevenaert A
Clin Neurol Neurosurg; 2007 Jan; 109(1):63-70. PubMed ID: 16488532
[TBL] [Abstract] [Full Text] [Related]
10. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function.
Lundholm K; Daneryd P; Bosaeus I; Körner U; Lindholm E
Cancer; 2004 May; 100(9):1967-77. PubMed ID: 15112279
[TBL] [Abstract] [Full Text] [Related]
11. Second primary malignancies in thyroid cancer patients.
Rubino C; de Vathaire F; Dottorini ME; Hall P; Schvartz C; Couette JE; Dondon MG; Abbas MT; Langlois C; Schlumberger M
Br J Cancer; 2003 Nov; 89(9):1638-44. PubMed ID: 14583762
[TBL] [Abstract] [Full Text] [Related]
